The scenarios of cost
subfertility
The research perspective of the study was that of the healthcare system and non-medical costs and costs of time and loss of productivity were not incorporated in the analysis. Costs were indexed to 2021, and no discounting was applied due to the short time horizon employed.The scenarios reflected the direct medical cost of IVF for subfertility treatment in China. We estimated the cost of IVF separately based upon the local charges on an out-of-pocket basis.The costs of IVF for patients were from a tertiary public hospital, which was one of 14 centers in the CESE-PGS trial, located in Jiangsu Province, China from 2019 to 2021.